OraSure Technologies, Inc.
NASDAQ:OSURMedical - Instruments & Supplies
-$0.16 today
- Market cap
- $247.88M
- Beta
- 1.01
- P/E (TTM)
- -4.0
- EPS (TTM)
- -$1.08
Volume 0.49M
Average 0.61M
OSUR Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
OraSure Technologies, Inc.NASDAQ: OSUR
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development grows, but more slowly than its trailing trend
Q1 FY2026 research & development of $13.31M rose 38.6% year over year, behind the +68.7% change in trailing-twelve-month research & development. Sequentially, it rose 16.5% from the prior quarter. Over 3 fiscal years it compounded at +5.5% a year.
Context
- Research & development amounted to 37.0% of revenue in FY2025, up 23.8 pp from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +38.6% toward the trailing-twelve-month pace of +68.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 42.53M USD
- Year-over-year change
- +74.2%
- 4-year CAGR
- +5.6%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 42.53M | +74.2% |
| FY2024 | 2024-12-31 | 24.42M | -26.4% |
| FY2023 | 2023-12-31 | 33.16M | -8.5% |
| FY2022 | 2022-12-31 | 36.24M | +6.0% |
| FY2021 | 2021-12-31 | 34.17M | — |
Research & Development vs competitors
How OSUR compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +68.7% is the 2nd highest of 9, against a peer median of -3.0%.
- Research & development amounts to 40.9% of revenue for OSUR, versus a peer median of 58.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $85.68M USD | +76.6% | +218.7% | 13864.6% | |
| LTM Mar 2026 | $46.96M USD | +41.8% | +36.4% | — | |
| LTM Mar 2026 | $46.23M USD | +68.7% | +5.5% | 40.9% | |
| LTM Mar 2026 | €42.56M EUR | +17.3% | +39.2% | 260.8% | |
| LTM Mar 2026 | $40.3M USD | -12.6% | +4.1% | — | |
| LTM Mar 2026 | $21.15M USD | -1.0% | +12.6% | 112.1% | |
| LTM Mar 2026 | $6.33M USD | -47.4% | -11.0% | 4.2% | |
| LTM Mar 2026 | $4.57M USD | -56.9% | -5.0% | 4.0% | |
| LTM Mar 2026 | $3.93M USD | — | — | — | |
| LTM Mar 2026 | $668K USD | -5.0% | +10.7% | 1.8% | |
| Peer median (excluding OSUR) | — | -3.0% | +11.6% | 58.1% | |
Competitors are the stored peer set for OSUR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 233.67M | 387.48M | 405.47M | 185.83M | 115.02M |
| Cost of Revenue | 116.07M | 239.04M | 226.05M | 109.6M | 66.82M |
| Gross Profit | 117.6M | 148.44M | 179.42M | 76.23M | 48.2M |
| Gross Margin | 50.3% | 38.3% | 44.2% | 41.0% | 41.9% |
| Research & Development | 34.17M | 36.24M | 33.16M | 24.42M | 42.53M |
| Selling, General & Admin | 95.08M | 117.44M | 92.18M | 72.41M | 73.79M |
| Operating Expenses | 129.25M | 153.68M | 125.34M | 96.83M | 116.32M |
| Depreciation & Amortization | 11.66M | 14M | 19.9M | 10.87M | 9.97M |
| EBITDA | 2.37M | (1.68M) | 76.16M | (6.83M) | (56.96M) |
| EBITDA Margin | 1.0% | -0.4% | 18.8% | -3.7% | -49.5% |
| Operating Income | (11.65M) | (5.24M) | 54.08M | (20.6M) | (68.12M) |
| Operating Margin | -5.0% | -1.4% | 13.3% | -11.1% | -59.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 2.36M | (10.43M) | 2.18M | 2.9M | 1.19M |
| Income Before Tax | (9.29M) | (15.68M) | 56.26M | (17.7M) | (66.93M) |
| Pre-Tax Margin | -4.0% | -4.0% | 13.9% | -9.5% | -58.2% |
| Income Tax Expense | 13.71M | 1.46M | 2.6M | 1.8M | 1.8M |
| Net Income | (23M) | (17.13M) | 53.66M | (19.5M) | (68.73M) |
| Net Margin | -9.8% | -4.4% | 13.2% | -10.5% | -59.8% |
| EPS (Basic) | (0.32) | (0.25) | 0.73 | (0.26) | (0.94) |
| EPS (Diluted) | (0.32) | (0.25) | 0.72 | (0.26) | (0.94) |
| Weighted Avg Shares | 71.98M | 72.51M | 73.35M | 74.43M | 73.49M |
| Weighted Avg Shares (Diluted) | 71.98M | 72.51M | 74.39M | 74.43M | 73.49M |
OraSure Technologies, Inc.
NASDAQ:OSUR
Intrinsic Alpha fair value
Locked
Current Price
$3.59
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.